Manufacturing

NextPharma has acquired a leading European chewable tablets manufacturing site from Takeda in Asker, Norway.

Nathan Pettus, president of Process Systems and Solutions at Emerson, discusses how automation is impacting recent sustainability technologies and solutions.

Sartorius’ acquisition of Polyplus is designed to strengthen its cell and gene therapy capabilities.

Interviews hosted on-site at the Emerson Automation Exchange in Grapevine, Texas, from October 24th to October 28th, 2022.

Mass spectrometric techniques are providing insights in critical RNA-based therapeutic areas.

A CPHI North America panel discussion forewarns that CDMO supply chains are potentially the biggest single risk to product resilience.

Webinar Date/Time: Tue, May 23, 2023 11:00 AM EDT

As new manufacturing processes and technologies are introduced to meet demand and overcome challenges, understanding also needs to improve to ensure the right balance is achieved.

Impurities and batch-to-batch variability present the biggest challenges.

Limitations in production platforms have impeded continuous manufacturing for advanced therapies.

Manufacturers and suppliers join forces to reduce the pharmaceutical industry’s carbon footprint.

Alternative approaches to freeze-drying are gaining popularity and will help to overcome some of the challenges associated with conventional lyophilization.

Contract testing services demonstrate a major increase in the speed and efficiency of testing using new testing methods and technologies.

The ROSS Model CDA-200 is fitted with multiple agitators for semi-continuous operation.

The Thermo Fisher Scientific Nicolet Summit X FTIR Spectrometer is a high-performance system designed for flexibility, ease of use, and high productivity.

Bio-Rad Laboratories StarBright Blue and StarBright Yellow dyes are conjugated to flow validated antibodies, supporting flow cytometry panel design in immunology design.

Bio-Rad Laboratories StarBright Blue and StarBright Yellow dyes are conjugated to flow validated antibodies, supporting flow cytometry panel design in immunology design.

Decreasing vein to vein time saves lives.

CDMO Exothera and biotech company Remedium are joining forces to scale up the manufacturing process for Remedium’s lead gene therapy candidate for treating osteoarthritis.

Takeda plans to build a new facility in Osaka, Japan, for the manufacture of plasma-derived therapies.

Webinar Date/Time: Tue, Apr 25, 2023 11:00 AM EDT

Curia is collaborating with Corning to advance biopharmaceutical continuous-flow development and manufacturing programs.

The services are based on the company’s PurePrep EasyClean (PEC) orthogonal peptide purification technology.

Sartorius BIA Separations and Teknova will collaborate to combine their technologies in an effort to streamline the downstream purification process.

Samsung Biologics plans to invest more than ₩1.9 trillion (US$1.5 billion) in the new Incheon, South Korea, facility, which will hold a manufacturing capacity of 180,000 L.